Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆

Authors: Xiaohua Wu, Jianqing Zhu, Rutie Yin, Jiaqian Yang, Jihong Liu, Junke Wang, Lingying Wu, Z.L. Liu, Yunong Gao, Dongsheng Wang, Ge Lou, Haizhen Yang, Qi Zhou, Beihua Kong, Yi Huang, L.P. Chen, Guangyao Li, Rui An, K. Wang, Yu Zhang, Xiaojian Yan, Xin Lu, Weiguo Lü, Min Hao, Lai Wang, Heng Cui, Qingmei Chen, Guzhalinuer Abulizi, Xianghua Huang, Xusheng Tian, Hao Wen, C. Zhang, Jianmei Hou, Mansoor Raza Mirza - Annals of Oncology 2021 cited by 206